Sector consensus Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:02 13/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 284.37 USD | +0.84% |
|
+9.07% | +42.56% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 281 | -0.35% | 14 | ||||||
| 681.13 | +18.38% | 23 | ||||||
| 221.81 | +7.91% | 21 | ||||||
| 432.36 | +20.34% | 26 | ||||||
| 275.17 | +12.85% | 18 | ||||||
| 2,64,708.89 | +25.75% | 24 | ||||||
| 581.83 | -3.91% | 12 | ||||||
| 267.31 | +21.39% | 18 | ||||||
| 72.53 | +3.76% | 14 | ||||||
| 185.56 | +12.07% | 16 | ||||||
| 38.15 | -19.84% | 11 | ||||||
| 69.73 | -3.36% | 11 | ||||||
| 138.56 | +25.97% | 6 | ||||||
| 623.68 | +68.25% | 19 | ||||||
| 130.53 | -3.09% | 12 | ||||||
| 62.64 | +12.48% | 14 | ||||||
| 165.31 | +11.48% | 13 | ||||||
| 89.33 | +61.19% | 21 | ||||||
| 130.91 | +19.42% | 22 | ||||||
| 46.07 | +8.02% | 14 | ||||||
| Average | 13,460.13 | +14.94% | 16 | ||||||
| Weighted average by Cap. | 23,849.1 | +14.89% | 19 |
Select your edition
All financial news and data tailored to specific country editions
